Royal Philips has unveiled its new IntelliVue GuardianSoftware app to enable clinicians to better monitor patient conditions.
A part of the company’s General Care Solution portfolio, the app includes Early Warning Scoring (EWS) to offer advanced mobility and optimised workflows for clinicians. It has also secured 510(k) clearance from the US Food and Drug Administration (FDA).
The app can be used by clinicians to check related early warning scores and track vital signs captured by various compatible medical devices such as wearable biosensors.
In addition, the app is designed to alert clinicians on any potential patient deterioration signs prior to the occurrence of an adverse event, enabling them to make timely and effective interventions.
Royal Philips monitoring and analytics business leader Felix Baader said: “Clinicians need data in real-time to help them identify adverse events before they occur. Philips IntelliVue GuardianSoftware is always evolving to offer clinicians an intuitive tool to optimise efficiencies and clinical resources.
“With the introduction of the IGS mobile client app, clinicians can deploy resources more efficiently, and have a deeper view into their patients’ status.”
Philips IntelliVue GuardianSoftware tracks the number of patients in a hospital unit and automatically generates event notifications. This data is directly transmitted to clinicians’ mobile device.
The app utilises intelligent algorithms and predictive analytics to detect patient deterioration, notify caregivers and allow appropriate, timely intervention.
Apart from the new solution, Philips’ range of monitoring and analytics devices include continuous patient monitoring systems, as well as foetal, maternal, wearable and spot-check monitors.